


Ask a doctor about a prescription for Nemedan
Memantine Hydrochloride
Nemedan contains the active substance memantine and belongs to a group of medicines called anti-dementia medicines.
Memory loss in Alzheimer's disease is due to disturbances in the transmission of nerve impulses
that carry information in the brain. In the brain, there are so-called N-methyl-D-aspartate (NMDA) receptors,
which are involved in the transmission of nerve signals important for the learning process and for memory.
Nemedan belongs to a group of medicines called NMDA receptor antagonists. Nemedan, by acting on NMDA receptors,
improves the transmission of nerve impulses and memory.
Nemedan is used to treat patients with moderate to severe Alzheimer's disease.
When to be Extra Careful While Taking Nemedan
You should inform your doctor if:
In these situations, treatment with Nemedan should be carried out under close medical supervision,
and your doctor should regularly assess the effects of the therapy.
When memantine is given to patients with kidney problems, the doctor should closely monitor kidney function and,
if necessary, adjust the dose of the medicinal product.
You should avoid taking other medicines such as: amantadine (for the treatment of Parkinson's disease), ketamine (a substance usually used as an anesthetic), dextromethorphan (usually used to treat cough), and other NMDA receptor antagonist medicines.
Nemedan is not recommended for children and adolescents under 18 years of age.
You should inform your doctor or pharmacist about all medicines you are currently taking or have recently taken, even those that are available without a prescription.
In particular, taking Nemedan may cause changes in the effects of and require modification of the dose of the following medicines:
If you are hospitalized, you should inform your doctor that you are taking Nemedan.
You should inform your doctor if you have recently changed your diet (e.g., switched from a normal diet to a strict vegetarian diet) or have been diagnosed with renal tubular acidosis (RTA, excessive blood acidity due to kidney dysfunction) or severe urinary tract infections (structures through which urine flows). In these cases, it may be necessary for your doctor to adjust the dose of the medicinal product.
Women who are pregnant, breast-feeding, or planning to become pregnant should inform their doctor before starting treatment.
Pregnancy
Memantine is not recommended for use in pregnant women.
Breast-Feeding
Women taking Nemedan should not breast-feed.
Your doctor should inform you whether your illness allows you to drive or use machines safely.
Nemedan may also affect your reaction speed, making it inadvisable to drive or use machines.
Nemedan should always be taken as directed by your doctor. If you are unsure, consult your doctor or pharmacist.
The recommended dose of Nemedan for adults and the elderly is 20 mg once a day.
To minimize the risk of side effects, the dose of Nemedan should be increased gradually, according to the following scheme. Tablets of a different strength may also be used for this purpose.
At the beginning of treatment, Nemedan 5 mg film-coated tablets are used once a day. The dose will be increased by 5 mg every week until the recommended (maintenance) dose is reached.
The recommended maintenance dose is 20 mg once a day and is achieved at the beginning of the fourth week.
In patients with impaired kidney function, the dose of Nemedan is determined by the doctor.
In such patients, regular monitoring of kidney function is necessary, at intervals determined by the doctor.
Nemedan should be taken orally, once a day. To ensure the treatment is effective, the medicinal product should be taken regularly every day at the same time.
The tablets should be swallowed with water. The medicinal product can be taken with or without food.
Treatment should be continued for as long as it is beneficial. Your doctor will regularly assess the course of treatment.
If you have any doubts about taking this medicinal product, you should consult your doctor or pharmacist.
Like all medicines, Nemedan can cause side effects, although not everybody gets them.
Generally, the observed side effects are mild to moderate.
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Unknown(frequency cannot be estimated from the available data):
Alzheimer's disease is associated with depression, suicidal thoughts, and suicide. Such cases have been reported in patients treated with Nemedan.
If you experience any side effects, including those not listed in this package leaflet, you should inform your doctor or pharmacist.
Side effects can be reported directly to the Department for Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Jerozolimskie Avenue 181 C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
e-mail: [email protected]
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicinal product.
Keep this medicinal product out of the sight and reach of children.
Do not use Nemedan after the expiry date stated on the carton and blister after the words "Expiry Date".
The expiry date refers to the last day of that month.
There are no special precautions for the storage of the medicinal product.
After removal from the blister, the tablets can be stored for 7 days (e.g., in a pill box).
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is memantine hydrochloride. Each film-coated tablet contains 20 mg of memantine hydrochloride, equivalent to 16.62 mg of memantine.
The other ingredients are:
Core: microcrystalline cellulose, anhydrous colloidal silica, sodium croscarmellose, talc, magnesium stearate; and
Coating No: 28 Opadry Pink 20A34056:hypromellose 2910, hydroxypropylcellulose, talc, titanium dioxide (E 171), iron oxide red (E 172), iron oxide black (E 172).
Nemedan film-coated tablets are pink, oval, film-coated tablets with the imprint "20" on one side.
Nemedan film-coated tablets are available in blisters containing 30 tablets.
G.L. Pharma GmbH
Schlossplatz 1
A-8502 Lannach
Austria
To obtain more detailed information and information on the names of the medicinal product in other EEA member states, please contact the representative of the marketing authorization holder:
G.L. PHARMA POLAND Sp. z o.o.
Al. Jana Pawła II 61/313
01-031 Warsaw, Poland
Phone: 022/ 636 52 23; 636 53 02
e-mail: [email protected]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Nemedan – subject to medical assessment and local rules.